Haloxazolam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401549This classification denotes a benzodiazepine with the molecular formula C17H14BrFN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M448L2V8XP, chemically known as 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo(3,2-d)(1,4)benzodiazepin-6(5h)-one but generally known as haloxazolam, which bears US NIH Compound Identifier 3563. European Medicines Agency schedules Haloxazolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08010MIG. The term HALOXAZOLAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). HALOXAZOLAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule haloxazolam under HS 29349100 and SITC 51579. As of Q4 2014, HALOXAZOLAM remains the US FDA Preferred Term for this commodity. Haloxazolam bears US NLM identifiers UMLS ID C0120735 and NCI Concept Code C83744. SMILES: BRC1CC2C3(OCCN3CC(=O)NC2CC1)C1C(F)CCCC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.